Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Dec;39(12):2667–2670. doi: 10.1128/aac.39.12.2667

Emergence of multiple-antibiotic-resistant Streptococcus pneumoniae in Hong Kong.

K M Kam 1, K Y Luey 1, S M Fung 1, P P Yiu 1, T J Harden 1, M M Cheung 1
PMCID: PMC163009  PMID: 8592999

Abstract

Two hundred four strains of Streptococcus pneumoniae isolated in Hong Kong from January 1993 to May 1995 were analyzed for their antibiotic susceptibilities and epidemiological patterns. The ages of the patients from whom the strains were isolated from 1 month to 93 years (median, 53 years); the male-to-female ratio was 2.8, with a predominance of males in the pediatric group. Fifty-nine (28.9%) strains showed reduced penicillin susceptibility, including 40 (19.6%) with frank penicillin resistance (MIC > 1 microgram/ml). Tetracycline resistance alone was found in 28.4% of strains. Isolates with reduced penicillin susceptibility were more common in children than adults (40 versus 23.9%, P = 0.02), and penicillin resistance rates were significantly higher in hospitalized patients than in outpatients (39.5 versus 12.5%; p < 0.001). Penicillin resistance was significantly associated with resistance to ceftriaxone, erythromycin, and tetracycline (P < 0.01) but not with ofloxacin or vancomycin (P = 0.5). Among eight different patterns of resistance to three or more antibiotics, the commonest one (14.2%) was multiple resistance to penicillin, chloramphenicol, ceftriaxone, erythromycin, and tetracycline. Emergence of multiple-antibiotic-resistant S. pneumoniae reflects changes in the pneumococcus itself and the general indiscriminate use of antibiotics in treatment of respiratory infections in Hong Kong.

Full Text

The Full Text of this article is available as a PDF (175.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alonso J., Madrigal V., García-Fuentes M. Recurrent meningitis from a multiply resistant Streptococcus pneumoniae strain treated with erythromycin. Pediatr Infect Dis J. 1991 Mar;10(3):256–256. doi: 10.1097/00006454-199103000-00022. [DOI] [PubMed] [Google Scholar]
  2. Appelbaum P. C. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 1992 Jul;15(1):77–83. doi: 10.1093/clinids/15.1.77. [DOI] [PubMed] [Google Scholar]
  3. Asensi F., Pérez-Tamarit D., Otero M. C., Gallego M., Llanes S., Abadia C., Cantó E. Imipenem-cilastatin therapy in a child with meningitis caused by a multiply resistant pneumococcus. Pediatr Infect Dis J. 1989 Dec;8(12):895–895. doi: 10.1097/00006454-198912000-00019. [DOI] [PubMed] [Google Scholar]
  4. Bradley J. S., Connor J. D. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr Infect Dis J. 1991 Nov;10(11):871–873. [PubMed] [Google Scholar]
  5. Capeding M. R., Sombrero L. T., Lucero M. G., Saniel M. C. Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Filipino children. J Infect Dis. 1994 Feb;169(2):479–480. doi: 10.1093/infdis/169.2.479. [DOI] [PubMed] [Google Scholar]
  6. Cortese M. M., Wolff M., Almeido-Hill J., Reid R., Ketcham J., Santosham M. High incidence rates of invasive pneumococcal disease in the White Mountain Apache population. Arch Intern Med. 1992 Nov;152(11):2277–2282. [PubMed] [Google Scholar]
  7. Dagan R., Engelhard D., Piccard E., Englehard D [corrected to Engelhard D. ]. Epidemiology of invasive childhood pneumococcal infections in Israel. The Israeli Pediatric Bacteremia and Meningitis Group. JAMA. 1992 Dec 16;268(23):3328–3332. [PubMed] [Google Scholar]
  8. Fenoll A., Martín Bourgon C., Muñz R., Vicioso D., Casal J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis. 1991 Jan-Feb;13(1):56–60. doi: 10.1093/clinids/13.1.56. [DOI] [PubMed] [Google Scholar]
  9. Friedland I. R., Klugman K. P. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet. 1992 Feb 15;339(8790):405–408. doi: 10.1016/0140-6736(92)90087-j. [DOI] [PubMed] [Google Scholar]
  10. Friedland I. R., Shelton S., Paris M., Rinderknecht S., Ehrett S., Krisher K., McCracken G. H., Jr Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 1993 Mar;12(3):196–200. doi: 10.1097/00006454-199303000-00004. [DOI] [PubMed] [Google Scholar]
  11. Fu K. P., Lafredo S. C., Foleno B., Isaacson D. M., Barrett J. F., Tobia A. J., Rosenthale M. E. In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin. Antimicrob Agents Chemother. 1992 Apr;36(4):860–866. doi: 10.1128/aac.36.4.860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Geslin P., Buu-Hoi A., Frémaux A., Acar J. F. Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970-1990. Clin Infect Dis. 1992 Jul;15(1):95–98. doi: 10.1093/clinids/15.1.95. [DOI] [PubMed] [Google Scholar]
  13. John C. C. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin Infect Dis. 1994 Feb;18(2):188–193. doi: 10.1093/clinids/18.2.188. [DOI] [PubMed] [Google Scholar]
  14. King A., Phillips I. The comparative in-vitro activity of pefloxacin. J Antimicrob Chemother. 1986 Apr;17 (Suppl B):1–10. doi: 10.1093/jac/17.suppl_b.1. [DOI] [PubMed] [Google Scholar]
  15. Konno M., Yoshida S., Inoue M., Shimizu Y., Akizawa K., Uehara N., Takahashi S., Fujita K., Saito Y., Takahashi T. [An epidemiological study of penicillin-resistant Streptococcus pneumoniae in Japan]. Kansenshogaku Zasshi. 1994 Nov;68(11):1338–1351. [PubMed] [Google Scholar]
  16. Latorre C., Juncosa T., Sanfeliu I. Antibiotic resistance and serotypes of 100 Streptococcus pneumoniae strains isolated in a children's hospital in Barcelona, Spain. Antimicrob Agents Chemother. 1985 Aug;28(2):357–359. doi: 10.1128/aac.28.2.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lee H. J., Park J. Y., Jang S. H., Kim J. H., Kim E. C., Choi K. W. High incidence of resistance to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a university hospital in Korea. Clin Infect Dis. 1995 Apr;20(4):826–835. doi: 10.1093/clinids/20.4.826. [DOI] [PubMed] [Google Scholar]
  18. Leggiadro R. J. Penicillin- and cephalosporin-resistant Streptococcus pneumoniae: an emerging microbial threat. Pediatrics. 1994 Mar;93(3):500–503. [PubMed] [Google Scholar]
  19. Ligtvoet E. E., Wickerhoff-Minoggio T. In-vitro activity of pefloxacin compared with six other quinolones. J Antimicrob Chemother. 1985 Oct;16(4):485–490. doi: 10.1093/jac/16.4.485. [DOI] [PubMed] [Google Scholar]
  20. Ling J., Chau P. Y., Leung Y. K., Ng W. S., So S. Y. Antibiotic susceptibility of pneumococci and Haemophilus influenzae isolated from patients with acute exacerbations of chronic bronchitis: prevalence of tetracycline-resistant strains in Hong Kong. J Infect. 1983 Jan;6(1):33–37. doi: 10.1016/s0163-4453(83)95496-8. [DOI] [PubMed] [Google Scholar]
  21. Liñares J., Pallares R., Alonso T., Perez J. L., Ayats J., Gudiol F., Viladrich P. F., Martin R. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis. 1992 Jul;15(1):99–105. doi: 10.1093/clinids/15.1.99. [DOI] [PubMed] [Google Scholar]
  22. Marton A. Pneumococcal antimicrobial resistance: the problem in Hungary. Clin Infect Dis. 1992 Jul;15(1):106–111. doi: 10.1093/clinids/15.1.106. [DOI] [PubMed] [Google Scholar]
  23. Pérez-Trallero E., Garcia-Arenzana J. M., Jimenez J. A., Peris A. Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin. Eur J Clin Microbiol Infect Dis. 1990 Dec;9(12):905–906. doi: 10.1007/BF01967510. [DOI] [PubMed] [Google Scholar]
  24. Raoof S., Wollschlager C., Khan F. Treatment of respiratory tract infections with ciprofloxacin. J Antimicrob Chemother. 1986 Nov;18 (Suppl 500):139–145. doi: 10.1093/jac/18.supplement_d.139. [DOI] [PubMed] [Google Scholar]
  25. Sloas M. M., Barrett F. F., Chesney P. J., English B. K., Hill B. C., Tenover F. C., Leggiadro R. J. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 1992 Aug;11(8):662–666. [PubMed] [Google Scholar]
  26. Tsang D. N., Lai R. W., Lee K. C. Community-acquired meningitis due to penicillin-resistant Streptococcus pneumoniae. Clin Infect Dis. 1993 Feb;16(2):334–335. doi: 10.1093/clind/16.2.334. [DOI] [PubMed] [Google Scholar]
  27. Verhaegen J., Glupczynski Y., Verbist L., Blogie M., Vandeven J., Yourassowsky E., Vandepitte J. Capsular types and antibiotic sensitivity of pneumococci isolated from patients with serious infections in Belgium 1980 to 1988. Eur J Clin Microbiol Infect Dis. 1990 Jun;9(6):390–395. doi: 10.1007/BF01979467. [DOI] [PubMed] [Google Scholar]
  28. Watanakunakorn C., Greifenstein A., Stroh K., Jarjoura D. G., Blend D., Cugino A., Ognibene A. J. Pneumococcal bacteremia in three community teaching hospitals from 1980 to 1989. Chest. 1993 Apr;103(4):1152–1156. doi: 10.1378/chest.103.4.1152. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES